These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10083048)

  • 21. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infiltration pattern of rat heart allografts during rejection.
    Westra AL; Romaniuk A; Ryffa T; Wildevuur CR; Nieuwenhuis P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):374. PubMed ID: 3274787
    [No Abstract]   [Full Text] [Related]  

  • 23. Apoptosis as an instrument for immune regulation: study on a liver/small bowel tolerant rat model.
    Meyer D; Thorwarth M; Otto C; Gasser M; Gassel HJ; Timmermann W; Ulrichs K; Thiede A
    Transplant Proc; 1998 Aug; 30(5):2362-3. PubMed ID: 9723505
    [No Abstract]   [Full Text] [Related]  

  • 24. CD4-positive suppressor cells block allotransplant rejection.
    Yin D; Fathman CG
    J Immunol; 1995 Jun; 154(12):6339-45. PubMed ID: 7759872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does endotoxin accelerate rejection in a cardiac allograft model?
    Pirenne J; Médot M; Battafarano R; Benedetti E; Kim S; Dunn DL
    Transplant Proc; 1996 Oct; 28(5):2463-4. PubMed ID: 8907903
    [No Abstract]   [Full Text] [Related]  

  • 26. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
    Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
    Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effect of FK 506 and alpha/beta-T-cell antibody R73 on transplant vascular sclerosis after heterotopic rat heart transplantation.
    Silber RE; Lange V; Gassel AM; Ulrichs K
    Transplant Proc; 1998 Jun; 30(4):987-8. PubMed ID: 9636398
    [No Abstract]   [Full Text] [Related]  

  • 28. Variable prolongation of cardiac allograft survival following intraportal administration of donor antigens.
    Kise Y; Farges O; Buffello D; Mansour I; Bismuth H
    Transplantation; 1994 Aug; 58(4):527-30. PubMed ID: 8073526
    [No Abstract]   [Full Text] [Related]  

  • 29. Suppression of skin allograft rejection in mice by anti-CD3 monoclonal antibodies without cytokine-related side-effects.
    Vossen AC; Knulst AC; Tibbe GJ; van Oudenaren A; Baert MR; Benner R; Savelkoul HF
    Transplantation; 1994 Jul; 58(2):257-61. PubMed ID: 7913777
    [No Abstract]   [Full Text] [Related]  

  • 30. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine.
    Brunson ME; Tchervenkov JI; Alexander JW; Cofer BR
    Transplant Proc; 1991 Feb; 23(1 Pt 1):307-8. PubMed ID: 1990538
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of CD4 depleting and nondepleting monoclonal antibodies in the mouse heart allograft model.
    Han WR; Mottram PL; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2933-4. PubMed ID: 8105591
    [No Abstract]   [Full Text] [Related]  

  • 32. High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication.
    Wynn C; Pan F; Erickson L; Ebbs A; Kobayashi M; Jiang H
    Transplant Proc; 2002 Aug; 34(5):1387-9. PubMed ID: 12176408
    [No Abstract]   [Full Text] [Related]  

  • 33. Donor pretreatment: rat heart allograft survival and measurement of passenger leukocyte depletion with indium-111.
    Oluwole S; Hardy MA; Wang T; Satake K; Todd G; Reemtsma K; Nowygrod R
    Transplantation; 1980 Jul; 30(1):31-3. PubMed ID: 6994282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenously injected anti-cardiac myosin monoclonal antibody specifically demarcates cardiac rejection.
    Morris RE; DeValeria P; Skogen B; Pratt FP; Cheng PJ; Kim J; Clark WA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1053-5. PubMed ID: 3079015
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel effect of cyclosporine A on lymphocyte migration to allograft and recipient lymphoid tissue.
    Maksymowicz M; Ziolkowska A; Janczewska S; Cybulska E; Olszewski WL
    Transplant Proc; 1998 Dec; 30(8):4054-6. PubMed ID: 9865292
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of selective depletion of natural killer cells on allograft rejection.
    Markus PM; van den Brink M; Cai X; Harnaha J; Palomba L; Hiserodt JC; Cramer DV
    Transplant Proc; 1991 Feb; 23(1 Pt 1):178-9. PubMed ID: 1990508
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging.
    Tanaka M; Swijnenburg RJ; Gunawan F; Cao YA; Yang Y; Caffarelli AD; de Bruin JL; Contag CH; Robbins RC
    Circulation; 2005 Aug; 112(9 Suppl):I105-10. PubMed ID: 16159800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of tolerance to heart allografts in rats using posttransplant total lymphoid irradiation and anti-T cell antibodies.
    Woodley SL; Gurley KE; Hoffmann SL; Nicolls MR; Hagberg R; Clayberger C; Holm B; Wang X; Hall BM; Strober S
    Transplantation; 1993 Dec; 56(6):1443-7. PubMed ID: 8279017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody.
    Nicolls MR; Aversa GG; Pearce NW; Spinelli A; Berger MF; Gurley KE; Hall BM
    Transplantation; 1993 Mar; 55(3):459-68. PubMed ID: 8456460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.